Test of an interventional X-ray guidance device approved by the U.S. Food and Drug Administration in 2013 has the potential to reduce the radiation exposure of patients undergoing intra-arterial therapy (IAT) for liver cancer, say Johns Hopkins researchers. In a report prepared for presentation Dec. 3 at the 100th annual meeting of the Radiological Society of North America in Chicago), the researchers described the results of a clinical trial of the imaging system ...Thursday 27 November 2014
New Imaging System Alternative to Intra-arterial Therapy (IAT) : a Boon to Liver Cancer Patients
Test of an interventional X-ray guidance device approved by the U.S. Food and Drug Administration in 2013 has the potential to reduce the radiation exposure of patients undergoing intra-arterial therapy (IAT) for liver cancer, say Johns Hopkins researchers. In a report prepared for presentation Dec. 3 at the 100th annual meeting of the Radiological Society of North America in Chicago), the researchers described the results of a clinical trial of the imaging system ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment